Endocrine surgery
Medullary thyroid cancer
Nuclear medicine
Surgery
Thyroid cancer
Journal
American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
12
11
2021
revised:
15
02
2022
accepted:
25
03
2022
pubmed:
7
4
2022
medline:
26
7
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Many patients with Medullary Thyroid Cancer (MTC) will have persistent or recurrent disease after surgery requiring lifelong surveillance with imaging and tumor markers. The objective of this study is to evaluate the efficacy of Relevant studies were identified by conducting searches in Embase and PubMed and five studies were included in the final review. Five studies investigated per-patient sensitivity of When compared directly to
Sections du résumé
BACKGROUND
Many patients with Medullary Thyroid Cancer (MTC) will have persistent or recurrent disease after surgery requiring lifelong surveillance with imaging and tumor markers. The objective of this study is to evaluate the efficacy of
METHODS
Relevant studies were identified by conducting searches in Embase and PubMed and five studies were included in the final review.
RESULTS
Five studies investigated per-patient sensitivity of
CONCLUSIONS
When compared directly to
Identifiants
pubmed: 35382933
pii: S0002-9610(22)00224-0
doi: 10.1016/j.amjsurg.2022.03.046
pii:
doi:
Substances chimiques
Gallium Radioisotopes
0
Radiopharmaceuticals
0
copper dotatate CU-64
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
670-675Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.